首页> 美国政府科技报告 >Guidance for Waiving or Bridging of Mammalian Acute Toxicity Tests for Pesticides and Pesticide Products (Acute Oral, Acute Dermal, Acute Inhalation, Primary Eye, Primary Dermal, and Dermal Sensitization).
【24h】

Guidance for Waiving or Bridging of Mammalian Acute Toxicity Tests for Pesticides and Pesticide Products (Acute Oral, Acute Dermal, Acute Inhalation, Primary Eye, Primary Dermal, and Dermal Sensitization).

机译:对农药和农药产品(急性口服,急性皮肤,急性吸入,原发性眼,原发性皮肤和皮肤过敏)的哺乳动物急性毒性试验的放弃或桥接指南。

获取原文

摘要

The Office of Pesticide Programs (OPP), US EPA, has previously issued memoranda and other written documents describing criteria that can be cited by registrants to bridge data for or support a waiver of the requirement for mammalian acute toxicity data for pesticide technical active ingredients and pesticide end use formulations. These documents and explanations of criteria to support waiver and bridging requests have appeared in several Agency publications over the years, which can lead to confusion for registrants seeking accurate and updated guidance. This paper integrates information from various Agency documents and other memoranda, as relevant, into one document that can be used as a single reference source for acute toxicity waiver guidance as well as criteria for bridging of acute toxicity data. The purpose of this document is to consolidate information from these sources and provide a single source for consultation on the use of waiver and bridging criteria for acute toxicity testing.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号